
Epoetin beta - Wikipedia
Epoetin beta , sold under the brand name Neorecormon among others, is a synthetic, recombinant [4] form of erythropoietin, a protein that promotes the production of red blood cells. It is an erythropoiesis-stimulating agent (ESA) that is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy.
NeoRecormon - European Medicines Agency (EMA)
NeoRecormon is a medicine that stimulates red-blood-cell growth. It is available as a powder and solvent in a multidose vial, to be made up into a solution for injection. It is also available as a pre-filled syringe. NeoRecormon is available in various strengths from 500 to 50,000 international units (IU). It contains the active substance ...
Neorecormon: Uses, Dosage, Side Effects, Food Interaction & FAQ
2025年1月7日 · Neorecormon is produced by the kidney and used to make red blood cells. Neorecormon-stimulating agents are used often for people with long-term kidney disease and anemia.
NeoRecormon for anaemia did not live as long as people who did not receive these medicines. NeoRecormon contains the active ingredient epoetin beta (pronounced ee-poe-tin bee-ta). Epoetin beta is also known as recombinant human erythropoietin (pronounced ee-rith-roe-poy-tin). NeoRecormon belongs to a group of medicines known as hormones. The ...
NeoRecormon - patient leaflet, side effects, dosage
NeoRecormon is a solution in a pre-filled syringe for injection. The solution is colourless, clear to slightly opalescent. NeoRecormon 500 IU, 2000 IU, 3000 IU, 4000 IU, 5000 IU and 6000 IU: Each pre-filled syringe contains 0.3 ml solution. NeoRecormon 10,000 IU, 20,000 IU and 30,000 IU: Each pre-filled syringe contains 0.6 ml solution.
NeoRecormon 10,000 IU solution for injection in pre-filled syringe One pre-filled syringe with 0.6 ml solution for injection contains 10,000 international units (IU) corresponding to 83 micrograms epoetin beta* (recombinant human erythropoietin).
NeoRecormon (epoetin beta) - Roche
NeoRecormon contains the active substance epoetin beta and is a medicine that stimulates the growth of red blood cells. It is indicated for the treatment of patients with anaemia due to chronic kidney disease (CKD), or chemotherapy-induced anaemia (when treating certain cancers).
NeoRecormon (epoetin beta (rch)) information - myVMC
2017年9月25日 · NeoRecormon contains the active ingredient epoetin beta (pronounced ee-poe-tin bee-ta). Epoetin beta is also known as recombinant human erythropoietin (pronounced ee-rith-roe-poy-tin). NeoRecormon belongs to a group of medicines known as hormones.
NeoRecormon Drug / Medicine Information - News-Medical.net
2025年3月18日 · NeoRecormon contains the active ingredient epoetin beta. NeoRecormon is used to treat anaemia caused by chronic kidney disease.
NeoRecormon is used to treat anaemia caused by chonic kidney disease. Anaemia is caused by a lack of red blood cells or haemoglobin which transport oxygen in the blood.